Search Results 91-100 of 18126 for CLL

  1. Epidemiology of Monoclonal B-Cell Lymphocytosis Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Family history. People with a family history of chronic lymphocytic leukemia are about eight times more likely to develop CLL than are people without a family ...

  2. Chronic lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and scientists are actively studying new ways of treating chronic lymphocytic leukemia. Blood cell and bone marrow cancer research is ...

  3. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (IWCLL) criteria and having received at least 2 prior treatment regimens; CLL that warrants treatment; Clinically quantifiable ...

  4. Chronic lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...

  5. Analysis of Immunostaining during Mohs Micrographic Surgery to Improve Detection of Negative Surgical Margins in Patients with Squamous Cell Carcinoma and Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL) - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating ...

  6. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    AXL was identified as a potential therapeutic target in chronic lymphocytic leukemia (CLL). TP 0903 was shown to induce apoptosis in CLL B-cells taken directly ...

  7. Chronic lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and scientists are actively studying new ways of treating chronic lymphocytic leukemia. Blood cell and bone marrow cancer research is ...

  8. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia (B-CLL). Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells ...

  9. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  10. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.